Search

Larry Sun Tsai

from Santa Clara, CA
Age ~49
Get Report
Also known as:
Larry S Tsai, Larry Tsal, Larry Tisa
Phone and address:
1621 Cunningham St, Santa Clara, CA 95050
(408) 244-1438
Related to:
Hoang C Phung, 56Amy H Lam, 62Margaret Isai, 33Ivy Lam, 50Toan LamChris Lam
Connected to:
Alexander C Tsai, 58Annabelle S Tsai, 30Arnold Tsai, 66Astrid E Tsai, 50Belle H Tsai, 47Brenda P Tsai, 41Chai Y Tsai, 60Chenghung H Tsai, 49Chia H Tsai, 51Chimin M Tsai, 56

Larry Tsai Phones & Addresses

  • 1621 Cunningham St, Santa Clara, CA 95050 (408) 244-1438
  • 2624 Great Arbor Way, Union City, CA 94587 (510) 471-7437
  • Los Angeles, CA
  • 222 34Th St, New York, NY 10016 (212) 447-5077
  • San Francisco, CA
  • Alameda, CA

Resumes

Resumes

Larry Tsai Photo 1

Executive Director, Chief Operating Officer At Napa Valley Opera House

View page
Position:
Executive Director, Chief Operating Officer at Napa Valley Opera House
Location:
San Francisco Bay Area
Industry:
Performing Arts
Work:
Napa Valley Opera House
Executive Director, Chief Operating Officer
Copia 2003 - 2008
Chief Marketing Officer
Larry Tsai Photo 2

Independent Executive Office Professional

View page
Location:
San Francisco Bay Area
Industry:
Executive Office
Larry Tsai Photo 3

Managing Partner At Moone-Tsai Wines

View page
Location:
San Francisco Bay Area
Industry:
Consumer Goods
Larry Tsai Photo 4

Student At Academy Of Art University

View page
Location:
San Francisco Bay Area
Industry:
Computer Games
Larry Tsai Photo 5

Larry Tsai

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Larry Tsai
President
Numatter, Inc
935 Benecia Ave, Sunnyvale, CA 94085

Publications

Us Patents

Production Of Biologically Active Insulin-Like Growth Factor I From High Expression Host Cell Systems

View page
US Patent:
51588757, Oct 27, 1992
Filed:
Aug 25, 1989
Appl. No.:
7/398699
Inventors:
James A. Miller - Agoura CA
Philip K. Hsieh - Thousand Oaks CA
Larry B. Tsai - Agoura CA
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C12P 2102
C12P 2106
C07K 740
C07K 710
US Classification:
435 691
Abstract:
A novel method for refolding reduced IGF-I is provided in accordance with the present invention. The method is carried out by providing additional positive charge at the amino terminal end of the IGF-I molecule by the presence of a short leader sequence. The additional positive charge on the met-end of the IGF-I molecule has been found to enable recombinant IGF-I to refold simply by stirring solubilized inclusion body protein for between 2-16 hours, or overnight. The present invention also provides a novel fusion protein intermediate of IGF-I attached to the positively charged leader sequence.

Biomarkers For Predicting Response To Il-6 Antagonist In Covid-19 Pneumonia

View page
US Patent:
20230125415, Apr 27, 2023
Filed:
Mar 19, 2021
Appl. No.:
17/906908
Inventors:
- South San Francisco CA, US
Fang Cai - South San Francisco CA, US
Jennifer Tom - Hillsborough CA, US
Larry Wilse Tsai - Hillsborough CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/28
G01N 33/68
A61K 45/06
A61K 38/17
A61K 31/675
A61P 31/14
A61K 39/395
Abstract:
A method of treating pneumonia in a patient is disclosed comprising administering an effective amount of an IL-6 antagonist to a patient identified as having elevated ferritin level. Also disclosed is a method of achieving an improved clinical response in a patient with pneumonia comprising: a. measuring ferritin level in the patient, and b. administering an effective amount of an IL-6 antagonist to the patient identified as having an elevated ferritin level. The improved clinical response achieved includes: no death by Day 28, not mechanically ventilated by Day 28 (wherein the patient was not mechanically ventilated at baseline), better ordinal score at Day 28, and/or reduced time to hospital discharge within 28 days, compared to the clinical response in a patient with pneumonia and ferritin level that is not elevated. Moreover, a method of reducing time to hospital discharge in a patient with pneumonia comprising administering an effective amount of the IL-6 antagonist to the patient is disclosed, wherein the patient prior to treatment: a. is receiving non-invasive ventilation or high flow oxygen, or is intubated and being mechanically ventilated, and b. has been identified as having elevated IL-6 level.

Adaptable Multimedia Display System And Method

View page
US Patent:
20150339321, Nov 26, 2015
Filed:
May 22, 2015
Appl. No.:
14/719622
Inventors:
Andrew Butler - Palo Alto CA, US
Larry Tsai - Santa Clara CA, US
Carey Lee - Sunnyvale CA, US
F Brian Iannce - San Jose CA, US
John Gilbert - Applegate OR, US
Assignee:
Konnect Labs, Inc. - Sunnyvale CA
International Classification:
G06F 17/30
G06K 9/00
G10L 17/00
H04L 29/06
H04L 29/08
Abstract:
An adaptable Internet-connected multimedia display that displays photo or video streams from services such as Instagram or Facebook Photos, and that customizes the photo or video streams depending on environmental factors in its external environment.
Control profile
Larry Sun Tsai from Santa Clara, CA, age ~49 Get Report